News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Paolo Tarantino: Cure is a word we rarely use in metastatic breast cancer
Paolo Tarantino/X
May 13, 2025, 22:39

Paolo Tarantino: Cure is a word we rarely use in metastatic breast cancer

Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post on LinkedIn:

“Cure. A word we rarely use in patients with metastatic breast cancer, for good reasons. Yet, 25 years of targeting HER2 taught us that some HER2+ breast cancers, even when spread, can respond so well to anticancer treatment that never reappear.

Glad to contribute with an interview to this excellent article on the topic.”

Paolo Tarantino

More posts featuring CancerWorld.

PATINA trial: Phase III Trial of Palbociclib, Anti-HER2 Therapy, and Endocrine Therapy vs. Anti-HER2 Therapy and Endocrine Therapy in HR+/HER2+ Metastatic Breast Cancer

Paolo Tarantino: Cure is a word we rarely use in metastatic breast cancer

Breast Cancer cancer metastatic breast cancer OncoDaily Oncology Paolo Tarantino
Special Coverage
Oncolibrary
Jul 1, 2025, 12:44
MASCC 2025 Highlights: StrataXRT Prevents Severe Radiation Dermatitis in Large-Breasted Women Undergoing Prone Breast Radiotherapy
Blog
Jul 1, 2025, 10:46
INTERACT-EUROPE 100 Has Launched a New Round of Recruitment - European Cancer Organisation
Societies
Jul 1, 2025, 10:32
25 Posts Not To Miss From MASCC 2025
Blog
Jul 1, 2025, 10:30
Alina Comanescu: Urgent Call to Action - Don't Let Cancer Slip Off the EU Agenda
Blog
Jul 1, 2025, 10:16
Survivor Cindy Pursues Nursing in Ghana Fifteen Years After Kidney Cancer Diagnosis - World Child Cancer
Blog
Jul 1, 2025, 10:07
Treatment Optimisation: Making Cancer Treatment Accessible and Sustainable in Europe - EORTC
Blog
Jul 1, 2025, 09:57
Gevorg Tamamyan: To Me, MD Anderson Has Always Meant Dr. Kantarjian
Career
Jul 1, 2025, 09:56
Sidney Chahonyo is Breaking Barriers as the First Survivor on the Board of Childhood Cancer International
Blog
Jul 1, 2025, 09:34
Jasmine Kamboj: Congratulating the New Co-Leads of the Community of Practice Policy
Dialogues
Jul 1, 2025, 09:27
Top Biotechs at ASCO: Ruthie Davi on AI and Data Insights in Platinum-Resistant Ovarian Cancer
Blog
Jul 1, 2025, 09:25
Alexandre Chan's Final Reflection on MASCC 2025
Dialogues
Jul 1, 2025, 09:21
Women Leaders in Oncology: Nina Mojas on GSK’s Oncology Growth and Innovation Strategy